A Single-Center, Open-Label, Phase II, Proof-of-Concept Study with Pasireotide LAR in patients with progressive medullary thyroid cancer (MTC): preliminary data Abstract #586
Abstract content not available
Don’t be disappointed – you can look forward to seeing the full abstract from 10 March 2020 onwards.
Further abstracts you may be interested in
No result